Segall Bryant & Hamill LLC bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 16,419 shares of the company's stock, valued at approximately $1,624,000. Segall Bryant & Hamill LLC owned approximately 0.09% of Addus HomeCare at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of ADUS. Natixis raised its holdings in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at about $77,000. Harvest Fund Management Co. Ltd purchased a new position in Addus HomeCare during the fourth quarter worth about $86,000. Cibc World Markets Corp purchased a new position in Addus HomeCare during the fourth quarter worth about $204,000. Finally, Defined Financial Planning LLC purchased a new position in Addus HomeCare during the fourth quarter worth about $270,000. Institutional investors and hedge funds own 95.35% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the stock. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. JMP Securities reissued a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a report on Wednesday, July 16th. Finally, Macquarie reissued an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $142.57.
Read Our Latest Stock Analysis on Addus HomeCare
Insider Buying and Selling at Addus HomeCare
In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 4.60% of the company's stock.
Addus HomeCare Trading Up 1.5%
NASDAQ ADUS traded up $1.68 during mid-day trading on Wednesday, reaching $110.39. 95,931 shares of the stock were exchanged, compared to its average volume of 165,577. The stock has a market capitalization of $2.03 billion, a PE ratio of 24.92, a PEG ratio of 1.54 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. The business's fifty day simple moving average is $112.35 and its 200 day simple moving average is $109.68. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The firm had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same quarter in the previous year, the firm posted $1.21 EPS. The firm's quarterly revenue was up 20.3% on a year-over-year basis. On average, research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.